Research Participants

Subjects come first for the BRANY Institutional Review Board (IRB). We are dedicated to protecting the rights and ensuring the welfare of all human research subjects, as evidenced by our commitment to ethical research and rigorous research oversight.

This section of our website provides current and potential research participants with useful information about participating in clinical trials, the protections they are entitled to, and a method to provide feedback and concerns about specific clinical trials.


Search Trials

Our Newest Trials

Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Nonalcoholic Steatohepatitis (NASH)

SPI-POZ-202 non-small cell lung cancer

informCLL™ A Disease Registry for Patients with Chronic Lymphocytic Leukemia

Non-squamous Non-small Cell Lung Cancer (NSCLC)

Avelumab in Pediatric Cancer

Paroxysmal Atrial Fibrillation

Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Unresectable Hepatocellular Carcinoma

Patients with Previously Untreated Acute Myeloid Leukemia